Literature DB >> 19569974

Detection of Leishmania in unaffected mucosal tissues of patients with cutaneous leishmaniasis caused by Leishmania (Viannia) species.

Roger Adrian Figueroa1, Leyder Elena Lozano, Ibeth Cristina Romero, Maria Teresa Cardona, Martin Prager, Robinson Pacheco, Yira Rosalba Diaz, Jair Alexander Tellez, Nancy Gore Saravia.   

Abstract

BACKGROUND: Leishmania (Viannia) species are the principal cause of mucosal leishmaniasis. The natural history and pathogenesis of mucosal disease are enigmatic. Parasitological evaluation of mucosal tissues has been constrained by the invasiveness of conventional sampling methods.
METHODS: We evaluated the presence of Leishmania in the mucosa of 26 patients with cutaneous leishmaniasis and 2 patients with mucocutaneous leishmaniasis. Swab samples of the nasal mucosa, tonsils, and conjunctiva were analyzed using polymerase chain reaction with LV-B1 primers and Southern blot hybridization.
RESULTS: Two patients with mucocutaneous leishmaniasis and 21 (81%) of 26 patients with cutaneous leishmaniasis had Leishmania kinetoplast minicircle DNA (kDNA) in mucosal tissues. kDNA was amplified from swab samples of nasal mucosa from 14 (58%) of 24 patients, tonsils from 13 (46%) of 28 patients, and conjunctiva from 6 (25%) of 24 patients. kDNA was detected in the mucosa of patients with cutaneous disease caused by Leishmania panamensis, Leishmania guyanensis, and Leishmania braziliensis.
CONCLUSION: The asymptomatic presence of parasites in mucosal tissues may be common in patients with Leishmania (Viannia) infection.

Entities:  

Mesh:

Year:  2009        PMID: 19569974      PMCID: PMC5056532          DOI: 10.1086/600109

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Mucosal leishmaniasis: quantitative nasal cytology as a marker of disease activity and indicator of healing.

Authors:  J B Guerreiro; A A Cruz; A Barral; H A Lessa; H Rocha; E M Carvalho
Journal:  Ann Otol Rhinol Laryngol       Date:  2000-01       Impact factor: 1.547

2.  Visceral leishmaniasis masquerading as a nasopharyngeal tumour. Report of a case.

Authors:  S R Naik; V K Vinayak; P Talwar; S Sehgal; Y N Mehra; B N Dutta; P N Chhuttani
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

Review 3.  Tumour necrosis factor alpha and mucocutaneous leishmaniasis.

Authors:  J M Blackwell
Journal:  Parasitol Today       Date:  1999-02

4.  Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients.

Authors:  A Schubach; F Haddad; M P Oliveira-Neto; W Degrave; C Pirmez; G Grimaldi; O Fernandes
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

5.  Heterogeneity, geographic distribution, and pathogenicity of serodemes of Leishmania viannia in Colombia.

Authors:  Nancy Gore Saravia; Kristen Weigle; Claudia Navas; Iris Segura; Liliana Valderrama; Anais Zully Valencia; Blanca Escorcia; Diane McMahon-Pratt
Journal:  Am J Trop Med Hyg       Date:  2002-06       Impact factor: 2.345

6.  Post kala-azar uveitis.

Authors:  W Dechant; P H Rees; P A Kager; V Klauss; H Adala
Journal:  Br J Ophthalmol       Date:  1980-09       Impact factor: 4.638

7.  Dissemination in cutaneous leishmaniasis. 3. Lymph node involvement.

Authors:  Y al-Gindan; R Kubba; A M el-Hassan; A H Omer; M K Kutty; M B Saeed
Journal:  Int J Dermatol       Date:  1989-05       Impact factor: 2.736

8.  Epidemiologic, genetic, and clinical associations among phenotypically distinct populations of Leishmania (Viannia) in Colombia.

Authors:  N G Saravia; I Segura; A F Holguin; C Santrich; L Valderrama; C Ocampo
Journal:  Am J Trop Med Hyg       Date:  1998-07       Impact factor: 2.345

9.  Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis.

Authors:  A Barral; J Guerreiro; G Bomfim; D Correia; M Barral-Netto; E M Carvalho
Journal:  Am J Trop Med Hyg       Date:  1995-09       Impact factor: 2.345

10.  Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment.

Authors:  A M el-Hassan; S E Meredith; H I Yagi; E A Khalil; H W Ghalib; K Abbas; E E Zijlstra; C C Kroon; G J Schoone; A Ismail
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Nov-Dec       Impact factor: 2.184

View more
  28 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

Review 2.  Leishmaniasis in the United States: treatment in 2012.

Authors:  Henry W Murray
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

3.  Diagnostic performance of filter paper lesion impression PCR for secondarily infected ulcers and nonulcerative lesions caused by cutaneous leishmaniasis.

Authors:  Andrea K Boggild; Ana Pilar Ramos; Braulio Mark Valencia; Nicolas Veland; Flor Calderon; Jorge Arevalo; Donald E Low; Alejandro Llanos-Cuentas
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

Review 4.  The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.

Authors:  Mary-Anne Hartley; Stefan Drexler; Catherine Ronet; Stephen M Beverley; Nicolas Fasel
Journal:  Trends Parasitol       Date:  2014-06-20

5.  Sensitive diagnosis of cutaneous leishmaniasis by lesion swab sampling coupled to qPCR.

Authors:  Emily R Adams; Maria Adelaida Gomez; Laura Scheske; Ruby Rios; Ricardo Marquez; Alexandra Cossio; Audrey Albertini; Henk Schallig; Nancy Gore Saravia
Journal:  Parasitology       Date:  2014-08-11       Impact factor: 3.234

6.  Phlebotomine vector ecology in the domestic transmission of American cutaneous leishmaniasis in Chaparral, Colombia.

Authors:  Cristina Ferro; Dairo Marín; Rafael Góngora; María C Carrasquilla; Jorge E Trujillo; Norma K Rueda; Jaime Marín; Carlos Valderrama-Ardila; Neal Alexander; Mauricio Pérez; Leonard E Munstermann; Clara B Ocampo
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

7.  Diagnosis of mediterranean visceral leishmaniasis by detection of leishmania antibodies and leishmania DNA in oral fluid samples collected using an Oracol device.

Authors:  Yousr Galaï; Najla Chabchoub; Meriem Ben-Abid; Imène Ben-Abda; Nissaf Ben-Alaya-Bouafif; Fethi Amri; Karim Aoun; Aïda Bouratbine
Journal:  J Clin Microbiol       Date:  2011-06-29       Impact factor: 5.948

8.  Viability and burden of Leishmania in extralesional sites during human dermal leishmaniasis.

Authors:  Ibeth Romero; Jair Téllez; Yazmín Suárez; Maria Cardona; Roger Figueroa; Adrian Zelazny; Nancy Gore Saravia
Journal:  PLoS Negl Trop Dis       Date:  2010-09-14

9.  Leishmania life cycle images in the cutaneous cytologic smear of an immunocompetent patient.

Authors:  Roberta Zappacosta; Roberta Claudi; Salvatore Magnasco; Emma Dell'osa
Journal:  J Cytol       Date:  2010-01       Impact factor: 1.000

10.  Environmental factors associated with American cutaneous leishmaniasis in a new Andean focus in Colombia.

Authors:  C B Ocampo; M C Ferro; H Cadena; R Gongora; M Pérez; C H Valderrama-Ardila; R J Quinnell; N Alexander
Journal:  Trop Med Int Health       Date:  2012-08-12       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.